Affimed NV (Affimed NV) Price-to-Operating-Cash-Flow

: (As of Today)

View and export this data going back to 2014. Start your Free Trial

As of today (2024-04-19), Affimed NV's share price is $5.08. Affimed NV's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.96. Hence, Affimed NV's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Affimed NV's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, Affimed NV's highest Price-to-Operating-Cash-Flow Ratio was 5.22. The lowest was 2.83. And the median was 3.83.

AFMD's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.39
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Affimed NV's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $-1.86. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.96.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -41.70% per year.

During the past 12 years, Affimed NV's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.80% per year. The lowest was -46.40% per year. And the median was -14.40% per year.

Affimed NV Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Affimed NV's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Affimed NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																-	-	-	-	-

Competitive Comparison

For the Biotechnology subindustry, Affimed NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affimed NV Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Affimed NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Affimed NV's Price-to-Operating-Cash-Flow falls into.

Affimed NV Price-to-Operating-Cash-Flow Calculation

Affimed NV's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	5.08	/	-7.96
	=

Affimed NV's Share Price of today is $5.08.
Affimed NV's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.96.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Affimed NV Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Affimed NV's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Affimed NV (Affimed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

A28:Germany

Address

Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.